FI962445L - Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi - Google Patents

Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi Download PDF

Info

Publication number
FI962445L
FI962445L FI962445A FI962445A FI962445L FI 962445 L FI962445 L FI 962445L FI 962445 A FI962445 A FI 962445A FI 962445 A FI962445 A FI 962445A FI 962445 L FI962445 L FI 962445L
Authority
FI
Finland
Prior art keywords
preparation
paroxetine tablets
paroxetine
tablets
Prior art date
Application number
FI962445A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962445A7 (fi
FI962445A0 (fi
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI962445(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI962445A7 publication Critical patent/FI962445A7/fi
Publication of FI962445A0 publication Critical patent/FI962445A0/fi
Publication of FI962445L publication Critical patent/FI962445L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962445A 1993-12-15 1996-06-12 Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi FI962445L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (3)

Publication Number Publication Date
FI962445A7 FI962445A7 (fi) 1996-06-12
FI962445A0 FI962445A0 (fi) 1996-06-12
FI962445L true FI962445L (fi) 1996-06-12

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962445A FI962445L (fi) 1993-12-15 1996-06-12 Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi

Country Status (35)

Country Link
US (1) US6113944A (cs)
EP (1) EP0734260B2 (cs)
JP (1) JP3037757B2 (cs)
KR (1) KR100367796B1 (cs)
CN (1) CN1071116C (cs)
AP (1) AP540A (cs)
AT (1) ATE180973T1 (cs)
AU (1) AU697982B2 (cs)
BG (1) BG62755B1 (cs)
BR (1) BR9408219A (cs)
CA (4) CA2214575C (cs)
CZ (1) CZ287891B6 (cs)
DE (1) DE69419033T2 (cs)
DK (1) DK0734260T4 (cs)
DZ (1) DZ1835A1 (cs)
ES (1) ES2132610T5 (cs)
FI (1) FI962445L (cs)
GB (1) GB9325644D0 (cs)
GR (1) GR3031047T3 (cs)
HU (1) HUT75880A (cs)
IL (1) IL111978A (cs)
MA (1) MA23395A1 (cs)
MY (1) MY112123A (cs)
NO (1) NO307366B1 (cs)
NZ (1) NZ277790A (cs)
OA (1) OA10297A (cs)
PL (1) PL314980A1 (cs)
RO (1) RO115413B1 (cs)
RU (1) RU2146141C1 (cs)
SA (1) SA94150373B1 (cs)
SI (1) SI0734260T2 (cs)
SK (1) SK282620B6 (cs)
UA (1) UA42745C2 (cs)
WO (1) WO1995016448A1 (cs)
ZA (1) ZA949900B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
TR200201156T2 (tr) 1997-06-10 2002-07-22 Synthon B.V. 4-Fenilpiperidin bileşimleri.
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
DE60217932T2 (de) 2001-07-31 2007-08-30 H. Lundbeck A/S, Valby Kristalline Zusammensetzung enthaltend Escitalopram
AU2002330771A1 (en) * 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine
WO2003057151A2 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
AU2005265174A1 (en) * 2004-06-23 2006-01-26 Merck & Co., Inc. Estrogen receptor modulators
EP1778183B1 (en) * 2004-08-18 2018-06-27 Synthon B.V. Liquid paroxetine compositions
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
WO2007058998A2 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (cs) * 1974-03-04 1975-09-11
ZA813205B (en) † 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
KR930702000A (ko) * 1990-11-24 1993-09-08 데이빗 로버츠 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
IL111978A (en) 2000-07-16
AP540A (en) 1996-09-20
CA2214575A1 (en) 1995-06-22
NO962547D0 (no) 1996-06-14
KR100367796B1 (ko) 2003-07-22
ES2132610T3 (es) 1999-08-16
BG62755B1 (bg) 2000-07-31
NZ277790A (en) 1998-02-26
PL314980A1 (en) 1996-09-30
AU697982B2 (en) 1998-10-22
MY112123A (en) 2001-04-30
RU2146141C1 (ru) 2000-03-10
GR3031047T3 (en) 1999-12-31
CZ176396A3 (en) 1996-09-11
ES2132610T5 (es) 2008-12-16
FI962445A7 (fi) 1996-06-12
DK0734260T4 (da) 2008-09-29
CZ287891B6 (cs) 2001-03-14
CA2274389A1 (en) 1995-06-22
UA42745C2 (uk) 2001-11-15
DK0734260T3 (da) 1999-11-15
DE69419033D1 (de) 1999-07-15
CA2274387A1 (en) 1995-06-22
JP3037757B2 (ja) 2000-05-08
SI0734260T1 (sl) 1999-08-31
SK282620B6 (sk) 2002-10-08
ATE180973T1 (de) 1999-06-15
AP9400704A0 (en) 1995-01-31
BG100648A (bg) 1997-02-28
CA2178637A1 (en) 1995-06-22
FI962445A0 (fi) 1996-06-12
NO307366B1 (no) 2000-03-27
CA2274389C (en) 2004-09-14
SA94150373B1 (ar) 2006-05-27
HUT75880A (en) 1997-05-28
DZ1835A1 (fr) 2002-02-17
NO962547L (no) 1996-06-14
CN1137236A (zh) 1996-12-04
CA2178637C (en) 1997-12-23
SI0734260T2 (sl) 2008-12-31
EP0734260A1 (en) 1996-10-02
SA94150373A (ar) 2005-12-03
HU9601665D0 (en) 1996-08-28
DE69419033T2 (de) 1999-11-25
EP0734260B2 (en) 2008-07-09
HK1012285A1 (en) 1999-07-30
BR9408219A (pt) 1997-08-26
US6113944A (en) 2000-09-05
CN1071116C (zh) 2001-09-19
EP0734260B1 (en) 1999-06-09
ZA949900B (en) 1995-10-10
WO1995016448A1 (en) 1995-06-22
MA23395A1 (fr) 1995-07-01
JPH09506602A (ja) 1997-06-30
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
IL111978A0 (en) 1995-03-15
AU1314595A (en) 1995-07-03
RO115413B1 (ro) 2000-02-28
CA2214575C (en) 1999-12-07
GB9325644D0 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
FI962445L (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
FI956270L (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI940585A7 (fi) Pinnoittamattomat tabletit ja menetelmä niiden valmistamiseksi
FI951305L (fi) Lääketieteellinen materiaali ja menetelmä sen valmistamiseksi
FI941137A7 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI973426L (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI943141A7 (fi) Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi
FI945476L (fi) Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi
FI944961L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI964028L (fi) Uusi farmaseuttinen formulaatio ja menetelmä
FI945900A7 (fi) Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksi
FI942745A7 (fi) Fluoreeniyhdisteitä ja valmistusmenetelmä
FI954246L (fi) Uusia A83543-yhdisteitä ja menetelmä niiden valmistamiseksi
FI973733L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI960751A7 (fi) Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi
FI960948L (fi) Pakkaus ja menetelmä mainitun pakkauksen tuottamiseksi
FI956080L (fi) Kuidutettu selluloosatuote ja menetelmä sen valmistamiseksi
FI953919A7 (fi) Pyrrolydeenimetyylijohdannaiset ja menetelmä niiden valmistamiseksi
FI942932A7 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI941836A7 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI955612A7 (fi) Menetelmä ja laite koneellista astioidenpuhdistusta varten
FI972988L (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
EE9800164A (et) Farmatseutiline kompositsioon ja meetod epitelioomi raviks
FI955123A0 (fi) Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi
FI973434A7 (fi) Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed